Clinical trial · Interventional
Effect of Preoperative Curcumin in Breast Cancer Patients
NCT03847623CI-TRIAL-00044256EPCunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Effect of curcumin on modulation of immune and inflammatory parameters in pre-operative patients
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Curcumin | Dietary Supplement | — | UNRESOLVED |
| Placebo | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Curcumin
- description
- Capsules, taken orally, 8g per day (Bi-daily dosing)
- interventionNames
- Dietary Supplement: Curcumin
- type
- PLACEBO_COMPARATOR
- label
- Placebo
- description
- Capsules, taken orally, bi-daily dosing
- interventionNames
- Other: Placebo
Primary outcomes (1)
- measure
- Tumour infiltrating lymphocytes (TILs)
- timeFrame
- For 2 to 4 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * Patients with operable breast cancer * Life expectancy of at least 3 months * Adequate organ function * No allergy to curcumin * Provides consent to participate in trial and adhere to the study protocol Exclusion Criteria: * Receiving concomitant radiotherapy, hormonal, immune therapy or other investigational drugs * Uncontrolled concurrent illness * Patient of anti platelet medications * Pregnant / breast feeding * Patients who are unable or unwilling to take curcumin, herbal remedies, or non-prescription medications * Patients with bleeding tendency, bleeding disorders and abnormal bleeding/clotting profile
References
Publications (0)
Data not yet available
No reference posted for this study.